drugset / Trial / NCT00900887
Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the efficacy of ocular topic antiinflammatory therapy (sodic nepafenac at 0.1% or ketorolac at 0.5%) to treat center point thickness secondary to selective photocoagulation in diabetics with clinically significant macular edema.
Timeline
- Start
- 2008-04
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 0.25 mg | Topical |
| Comparator | Nepafenac | Other / unclassified | 0.05 mg | Topical |